Rephonic
Artwork for Retina Synthesis

Retina Synthesis

Retina Synthesis
Geographic Atrophy
Diabetic Macular Edema
Neovascular AMD
Aflibercept
Diabetic Retinopathy
Gene Therapy
Clinical Trials
Artificial Intelligence
Retinopathy Of Prematurity
Tyrosine Kinase Inhibitors
Intravitreal Gene Therapy
Stanford University
Home OCT
Neovascular Age-Related Macular Degeneration
Faricimab
Photobiomodulation
Age-Related Macular Degeneration
Complement Inhibitors
Optogenetics
Ophthalmology

Retina Synthesis is a data-focused resource exploring therapies in development for retinal diseases.

PublishesWeeklyEpisodes201Founded6 years ago
Number of ListenersCategory
Education

Listen to this Podcast

Artwork for Retina Synthesis

Latest Episodes

Anton Kolomeyer walks through Vestrum Health data on intravitreal injection use from 2023 to 2025, presented at ASRS 2026. Bevacizumab climbed to about 30 percent of injections in 2025, passing aflibercept 2 milligrams, which fell from nearly 46 perc... more

Help Shape What’s Next on Retina Synthesis

Tell us what you enjoy and what you’d like to hear more of. Our listener survey is anonymous and takes under 3 minutes. Your feedback will help guide future episodes.

Take the survey:

docs.google.c... more

Dr. Ashkan Abbey, Director of Clinical Research at Texas Retina Associates, returns to discuss vonaprument (ANX007), a C1q inhibitor that blocks complement upstream of C3 and C5. In Phase 2 ARCHER, monthly treatment cut the risk of ≥15-letter vision ... more

Can a drop replace the needle in diabetic macular edema? Dr. Veeral Sheth returns to Retina Synthesis to walk through DIAMOND-1 and DIAMOND-2, Oculis's twin Phase 3 trials of OCS-01, a high-concentration (15 mg/mL) topical dexamethasone formulated to... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Raj Maturi
Retina specialist at Midwest Eye Institute and clinical associate professor at Indiana University School of Medicine
Midwest Eye Institute
Episode: Gene Therapy for Geographic Atrophy: 12-Month ArMaDa Results
Ashkan Abbey
Director of Clinical Research at Texas Retina Associates
Texas Retina Associates
Episode: Preserving Vision, Not Just Slowing the Lesion: ARCHER II and Vonaprument
Dr. Veeral Sheth
Director of Clinical Research at University Retina Group in Chicago
University Retina Group in Chicago
Episode: The Drop That Dried the Macula but Missed on Vision: DIAMOND-1/2 and OCS-01
Dr. Roger Goldberg
Guest research clinician, Walnut Creek, California
Episode: Combined Anti-IL 6 and Anti-VEGF Therapy for Diabetic Macular Edema
Lloyd Clark
Physician discussing NeuroTech Encapsulated Cell Device
NeuroTech (MacTel program)
Episode: Surgery for Encapsulated Cell Therapy
Dr. Carl Regillo
Ophthalmologist at Wills Eye Hospital, expert in retinal diseases
Wills Eye Hospital
Episode: Results of the Eyepoint LUGANO Trial
Michael Singer
Clinician/researcher from San Antonio discussing MGB
Unspecified in transcript
Episode: A Subcutaneous TKI for the Treatment of Neovascular AMD and Diabetic Retinopathy
Dr. Ninel Gregori
Professor of Ophthalmology at Bascom Palmer Eye Institute and University of Miami Miller School of Medicine
Bascom Palmer Eye Institute, University of Miami
Episode: Gene Therapy for Inherited Retinal Degenerations
Gemmy Cheung
Head of the Medical Retina Division, Singapore National Eye Center
Singapore National Eye Center
Episode: Faricimab Therapy for Polypoidal Choroidal Vasculopathy (PCV)

Host

Carmen Puliofito
Ophthalmologist and clinician-interviewer focused on retinal disease therapies

Reviews

4.8 out of 5 stars from 19 ratings
  • MD PhD

    Great

    Apple Podcasts
    5
    Retina Physician
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

A reviewer with an MD and PhD describes the experience as great.

Talking Points

Recent interactions between the hosts and their guests.

The ASRS ReST Commitee
Q: So, if you're a retina specialist, what's your first line of approach? The ReST Committee?
Clinicians should stay alert when starting or switching medications and report adverse events through the pharmaceutical company, FDA, and ReST Committee. Reporting to the company also triggers FDA reporting, while the committee offers another route for collecting detailed clinical information.
The ASRS ReST Commitee
Q: Can you tell us what the ReST Committee is?
It is an ASRS committee established to give retina specialists another way to monitor the safety of devices and therapeutics that reach the market.
Preserving Vision, Not Just Slowing the Lesion: ARCHER II and Vonaprument
Q: Can you talk about that study design and how it differed from the Phase 2 trial, and how many patients were enrolled?
ARCHER II is a Phase 3 trial with about 659 patients, including foveal and non-foveal geographic atrophy. Participants were randomized two to one to monthly vonaprument or sham and followed for two years, with dual primary endpoints measuring loss of at least 15 letters at months 15 and 24.
Preserving Vision, Not Just Slowing the Lesion: ARCHER II and Vonaprument
Q: Tell us about this molecule and the whole story behind it.
Vonaprument inhibits C1q in the classical complement pathway, upstream of C3 and C5. Abbey says this more targeted approach could leave the alternative and lectin pathways active, while potentially limiting complement-related tagging and elimination of stressed photoreceptor synapses.
Gene Therapy for Geographic Atrophy: 12-Month ArMaDa Results
Q: And what were the findings?
At one year, the medium-dose group had 32 percent less lesion growth than the untreated control group; the high-dose group did not show the same benefit. In the Phase 3-eligible population, the reduction was about 31.5 percent.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Retina Synthesis

What is Retina Synthesis about and what kind of topics does it cover?

Clinician-led interviews examine therapies in development for retinal diseases, with close attention to clinical-trial results, treatment mechanisms, safety, and implications for patient care. Topics span age-related macular degeneration, diabetic macular edema, geographic atrophy, inherited retinal degenerations, and retinal inflammation, alongside emerging approaches such as gene and cell therapies, remote monitoring, and new drug-delivery methods.

Ophthalmologist Carmen Puliofito guides conversations with retina specialists, physician-scientists, and clinical researchers from academic centers and healthcare organizations. The discussions are notably data-focused, explaining trial design and endpoints while connecting anatomical findings... more

Where can I find podcast stats for Retina Synthesis?

Rephonic provides a wide range of podcast stats for Retina Synthesis. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Retina Synthesis and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Retina Synthesis get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Retina Synthesis, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Retina Synthesis?

Rephonic provides comprehensive predictive audience data for Retina Synthesis, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Retina Synthesis have?

To see how many followers or subscribers Retina Synthesis has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Retina Synthesis?

These podcasts share a similar audience with Retina Synthesis:

1. New Retina Radio by Eyetube
2. RETINA Journal Podcasts
3. Straight From The Cutter's Mouth: A Retina Podcast
4. ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
5. Talking Euretina

How many episodes of Retina Synthesis are there?

Retina Synthesis launched 6 years ago and published 201 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Retina Synthesis?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Retina Synthesis?

Rephonic pulls ratings and reviews for Retina Synthesis from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Retina Synthesis?

Rephonic provides full transcripts for episodes of Retina Synthesis. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Retina Synthesis?

Recent guests on Retina Synthesis include:

1. Raj Maturi
2. Ashkan Abbey
3. Dr. Veeral Sheth
4. Dr. Roger Goldberg
5. Lloyd Clark
6. Dr. Carl Regillo
7. Michael Singer
8. Dr. Ninel Gregori

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days